Stanford University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Stanford University sits in the top decile of US sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count).
Stanford University: 1,744 sponsored US clinical trials, 264 recruiting.
Stanford University sponsors 1,744 registered US clinical trials on ClinicalTrials.gov, 264 of them currently recruiting, and 1,122 completed. 137 of these trials are in Phase 3-4 (later-stage) and 402 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autism Spectrum Disorder, with 19 trials.
Top-decile sponsor footprint
Stanford University ranks in the top decile of sponsors by registered trial count (#8 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,744 total, page 32 of 35
Pilot Study to Evaluate a Method of Controlling High Blood Sugar in the Pediatric Intensive Care Unit
NCT00240149
Genetics of Recurrent Early Onset Major Depression
NCT00260182
Integrating the Genetic and Metabolic Faces of Obesity
NCT00285844
Molecular Genetic Studies of Childhood Brain Tumors and Blood Samples
NCT01650922
QOL & Functional Outcomes After Combined Modality Tx for Anal CA: Comparison of Conventional vs IMRT
NCT00568425
Clinical Experiment of Helicobacter Pylori Transmission
NCT00550368
Clinical and Biological Characteristics of Psychotic Depression
NCT00576095
Group Cognitive Behavioral Therapy to Treat Depression in an Epilepsy Clinic Setting
NCT00285740
Treatment of Psychotic Major Depression With Mifepristone
NCT00867360
Selegiline Patch for Treatment of Nicotine Dependence
NCT01330030
Breast Cancer Lymphedema: Role of Insulin Resistance/FOXC2
NCT00383604
An Open-Label Trial of Donepezil in Fragile X Syndrome
NCT00220584
Correlation of PET-CT Studies With Serum Protein Analysis
NCT00547742
Short Term Rescue Study of Olanzapine
NCT00186017
Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD
NCT00186628
Determination of Voiding Patterns of Children With Vesicoureteral Reflux
NCT00186199
A Pilot Trial of Adalimumab for the Treatment of Osteoarthritis
NCT00185562
Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM)
NCT00296296
Rituximab for Pediatric Renal Transplant Rejection
NCT00697996
Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status
NCT00383500
The Effect of Memantine on Brain Structure and Chemistry in Alzheimer's Disease Patients
NCT00255086
Impact of Hydrocortisone Administration on White Blood Cell Gene Expression in Patients With Severe Sepsis
NCT00185783
Subtotal Resection of Large Acoustic Neuromas With Possible Stereotactic Radiation Therapy
NCT01129687
Breathing Regulation Training for Individuals With Panic Disorder
NCT00183521
A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer
NCT00383487
Effect of Healing Touch on the Experience of Women Undergoing Treatment for Breast Cancer
NCT00533780
The Switch Study: The Role of Lamivudine/Emtricitabine (3TC/FTC) in Antiretroviral Regimens
NCT00152061
Hemofiltration for Respiratory Failure After Bone Marrow Transplantation
NCT00120575
Sublingual Immunotherapy Studies for Grass and Dust Mite Allergies
NCT01529437
Infant Aphakia Treatment Study (IATS)
NCT00212134
Expanding Rural Access: Distance Delivery of Support
NCT00186511
Walk to School and Physical Activity
NCT00186134
Effectiveness of Family-Based Versus Individual Psychotherapy in Treating Adolescents With Anorexia Nervosa
NCT00149786
Duloxetine for the Treatment of Dysthymia
NCT00185575
Understanding the Impact of Neighborhood Type on Physical Activity in Older Adults
NCT00094211
Light Treatment for Sleep/Wake Disturbances in Alzheimer's Disease
NCT00946530
Post Traumatic Stress Disorder (PTSD), Sleep Disordered Breathing And Genetics: Effects On Cognition
NCT01120847
Molecular Genetic and Pathological Studies of Anal Tumors
NCT00267787
TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD
NCT00185796
Cytokine Induced Killer Cells as Post-Transplant Immunotherapy Following Allogeneic Hematopoietic Cell Transplantation
NCT00185757
Treatment of Nicotine Dependence and Acute Depression
NCT00186446
Comparison of Once Daily Versus 8 Hour Dosing of Gentamicin for the Treatment of Intrapartum Chorioamnionitis
NCT00185991
Combining Antidepressant Medication and Psychotherapy for Insomnia to Improve Depression Outcome
NCT00149825
Treatment With Namenda in Women at Risk for Cognitive Decline
NCT00242632
Allogeneic Blood Stem Cell Transplantation for Patients With Life-Threatening Systemic Lupus Erythematosus
NCT00325741
Effect of Preoperative Pupil Size on Quality of Vision After Wavefront-Guided LASIK
NCT00889941
IntraLase vs Hansatome Flaps in LASIK
NCT00691431
Single Center Study Using Omalizumab in Subjects With Atopic Dermatitis
NCT01678092
A Pilot Clinical Trial of Sympathetic Blockade With Botulinum Toxin Type A to Treat Complex Regional Pain Syndrome (CRPS): a Randomized, Double-Blind, Controlled, Crossover Trial.
NCT00637533
90Y-IBRITUMOMAB Tiuxetan and AHCI With HD Chemotherapy and Autologous Transplantation for Relapsed or Resistant NHL
NCT00186589
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 193 |
| Phase 2 | 209 |
| Phase 3 | 51 |
| Phase 4 | 86 |
Therapeutic Areas
What is open in the Stanford University pipeline
264 recruiting of 1,744 indexed (15% open); 1,122 completed (64%).
Phase mix: 137 late (III/IV) vs 402 early (I/II) (early-phase heavy).
Top condition: Autism Spectrum Disorder (19 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.